Increased prevalence of glycoprotein IIb/IIIa Leu33Pro polymorphism in term infants with grade I intracranial haemorrhage

Neuropediatrics

Volumn 37, Issue 2, 2006, Pages 67-71

  Havasi, V ^a   Komlosi K ^a   Bene, J ^a   Melegh, Béla ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Factor V Leiden; Increased prevalence of PLA2; Intraventricular haemorrhage

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN RECEPTOR; LEUCINE; PROLINE;

ALLELE; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA POLYMORPHISM; GENE FREQUENCY; GENE MUTATION; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; TERM BIRTH;

CASE-CONTROL STUDIES; FACTOR V; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTRACRANIAL HEMORRHAGES; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC;

EID: 33745521774     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-923980     Document Type: Article

References (34)

1. Alberts MJ. Stroke genetics update. Stroke 2003; 34: 342-344
2. Aronis S, Bouza H, Pergantou H, Kapsimalis Z, Platokouki H, Xanthou M. Prothrombotic factors in neonates with cerebral thrombosis and intraventricular hemorrhage. Acta Paediatr Suppl 2002; 91: 87-91
3. Birchall JE, Murphy MF, Kaplan C, Kroll H. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol 2003; 122: 275-288
4. Blickman JG, Jaramillo D, Cleveland RH. Neonatal cranial ultrasonography. Curr Probl Diagn Radiol 1991; 20: 91-119
5. Carter AM, Catto AJ, Bamford JM, Grant PJ. Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol 1998; 18: 1124-1131
6. Davoren A, Curtis BR, Aster RH, McFarland JG. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004; 44: 1220-1225
7. Erhardt E, Stankovics J, Molnar D, Adamovich K, Melegh B. High prevalence of factor V Leiden mutation in mothers of premature neonates. Biol Neonate 2000; 78: 145-146
8. Feng D, Lindpaintner K, Larson MG et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999; 19: 1142-1147
9. Fullard JF. The role of the platelet glycoprotein IIb/IIIa in thrombosis and haemostasis. Curr Pharm Des 2004; 10: 1567-1576
10. Gopel W, Fehlau K, Kohl M, Schultz C, Moller J. HPA-1 carrier status and thrombocytopenia in preterm infants with a birth weight below 1500 grams. J Perinat Med 2002; 30: 176-178
11. Gopel W, Gortner L, Kohlmann T, Schultz C, Moller J. Low prevalence of large intraventricular haemorrhage in very low birth weight infants carrying the factor V Leiden or prothrombin G20210A mutation. Acta Paediatr 2001; 90: 1021-1024
12. Herman JH, Jumbelic MI, Ancona RJ, Kickler TS. In utero cerebral hemorrhage in alloimmune thrombocytopenia. Am J Pediatr Hematol Oncol 1986; 8: 312-317
13. Humphries SE, Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004; 3: 227-235
14. Israels SJ, Rand ML, Michelson AD. Neonatal platelet function. Semin Thromb Hemost 2003; 29: 363-372
15. Kenet G, Maayan-Metzger A, Rosenberg N et al. Thrombophilia does not increase risk for neonatal complications in preterm infants. Thromb Haemost 2003; 90: 823-828
16. Komlosi K, Havasi V, Bene J et al. Increased prevalence of factor V Leiden mutation in premature but not in full-term infants with grade I intracranial haemorrhage. Biol Neonate 2004; 87: 56-59
17. Lee R. Factor V Leiden: a clinical review. Am J Med Sci 2001; 322: 88-102
18. Linder N, Haskin O, Levit O et al. Risk factors for intraventricular hemorrhage in very low birth weight premature infants: a retrospective case-control study. Pediatrics 2003; 111: e590-e595
19. Melegh B, Stankovics J, Kis A et al. Increased prevalence of factor V Leiden mutation in neonatal intracranial haemorrhage [letter]. Eur J Pediatr 1998; 157: 261
20. Michelson AD. Platelet function in the newborn. Semin Thromb Hemost 1998; 24: 507-512
21. Michelson AD, Furman MI, Goldschmidt-Clermont P et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 2000; 101: 1013-1018
22. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83: 1778-1781
23. Osborn DA, Evans N, Kluckow M. Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics 2003; 112: 33-39
24. Perlman JM. White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome. Early Hum Dev 1998; 53: 99-120
25. Petaja J, Hiltunen L, Fellman V. Increased risk of intraventricular hemorrhage in preterm infants with thrombophilia. Pediatr Res 2001; 49: 643-646
26. Rayment R, Birchall J, Yarranton H et al. Neonatal alloimmune thrombocytopenia. BMJ 2003; 327: 331-332
27. Sajid M, Vijayan KV, Souza S, Bray PF. PlA polymorphism of integrin beta 3 differentially modulates cellular migration on extracellular matrix proteins. Arterioscler Thromb Vasc Biol 2002; 22: 1984-1989
28. Sosa ME. Alloimmune thrombocytopenia in the fetus: current management theories. J Perinat Neonatal Nurs 2003; 17: 181-189
29. Szolnoki Z, Somogyvari F, Kondacs A et al. Increased prevalence of platelet glycoprotein IIb/IIIa PLA2 allele in ischaemic stroke associated with large vessel pathology. Thromb Res 2003; 109: 265-269
30. Szolnoki Z, Somogyvari F, Szolics M, Szabo M, Fodor L. Common genetic mutations as possible aetiological factors in stroke. Eur Neurol 2001; 45: 119-120
31. Undas A, Brummel K, Musial J, Mann KG, Szczeklik A. Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 2001; 104: 2666-2672
32. Vijayan KV, Goldschmidt-Clermont PJ, Roos C, Bray PF. The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions. J Clin Invest 2000; 105: 793-802
33. Vohr BR, Allan WC, Westerveld M et al. School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2003; 111: e340-e346
34. Weiss EJ, Bray PF, Tayback M et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-1094